Capsaicin 8% Patch for Spinal Cord Injury Neuropathic Pain

• Status: Active, not recruiting
• Trial end date: 2022-07-01
• Target enrollment: 0
• Participant gender: All

Summary

A prospective case control study to determine the effectiveness and longevity of 8% capsaicin patch(es) in treating neuropathic pain in persons with spinal cord injury. The investigators will study spinal cord injury patients at South Texas Veterans Health Care Systems Spinal Cord Injury inpatient unit and outpatient clinics.

• Phase: N/A
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: The University of Texas Health Science Center at San Antonio
• Treatments: Capsaicin

Criteria

Inclusion Criteria:

1. Diagnosis of SCI

2. Neuropathic pain below level of injury

3. Surface area of pain no larger than 2 patches

4. Failed or did not tolerate gabapentin 3600mg/day, pregabalin 600mg/day, capsaicin cream and/or lidocaine cream

5. Skin over painful area intact

Exclusion Criteria:

1. Pain over open wound

2. Previously documented allergy to capsaicin

3. Superficial burn over area of pain

4. Premorbid (before SCI) neuropathic pain

5. HIV/AIDS neuropathy